Thursday, 11 September 2014

Monash University Chancellor tours ASPREE Centre

L-R : Prof John McNeil , Dr Alan Finkel,
Dr Carlene Britt & Prof Chris Reid
tour ASPREE Healthy Ageing Biobank Laboratory
Monash University Chancellor Dr Alan Finkel, yesterday toured the ASPREE National Co-ordinating Centre, with an update on progress of a clinical aspirin trial involving 18,000 older people.

Residents from Australia and the US are taking part in the multi-centre study investigating whether aspirin prolongs good health in older people. The trial, ASPREE (Aspirin in Reducing Events in the Elderly) will determine whether low dose aspirin delays or prevents the onset of age-related health problems such as dementia, cancer, and cardiovascular disease and will, for the first time, weigh the potential benefits versus the risks in healthy older people.

ASPREE is led by Monash University in Australia and the Berman Centre for Outcomes and Clinical Research in the US.

So far, more than 15,500 people aged 70 plus from Victoria, Tasmania, the ACT, southern NSW, Wollongong and SA are participating in the study. Recruitment is on target to close with 16,500 Australian participants by the end of the year. (19,000 in Australia and the US).

Yesterday’s tour, hosted by ASPREE PI Prof John McNeil, included the mobile clinical research vehicles and the ASPREE Healthy Ageing Biobank, which has stored blood samples from over 11,000 ASPREE participants. Research using these samples may result in the identification of predictors of disease or even good health, in older people.

No comments:

Post a Comment


Related Posts Plugin for WordPress, Blogger...